Search

everythinglearnresearchcommunity

for

Search:↓

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Cepharanthine shows promise as a natural anticancer treatment.

Upadacitinib effectively treats pyoderma gangrenosum.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Tofacitinib taken by mouth helps treat hair loss in children.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Tofacitinib may help regrow hair in alopecia areata patients.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

BMS-470539 reduces skin fibrosis and inflammation.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Erlotinib can cause hair loss and texture changes.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

The treatment is safe and shows promise for metastatic breast cancer.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

CTP-543 is generally safe for treating alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.